Zhou Xuanzhen, Jiang Chengxiao, Song Baiyang, Sun Shuben, Yan Zejun
Department of Urology, Ningbo Clinical Research Center for Urological Disease, Zhejiang Engineering Research Center of Innovative technologies and diagnostic and therapeutic equipment for urinary system diseases, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Department of Urology, Xiangshan Frist People's Hospital Medical and Health Group, Xiangshan, China.
Prev Med Rep. 2025 Apr 8;53:103060. doi: 10.1016/j.pmedr.2025.103060. eCollection 2025 May.
Emerging evidence suggests that diet modulates gut microbiota, which in turn influences chronic kidney disease (CKD) progression. This study investigates the association between the newly proposed Dietary Index for Gut Microbiota (DI-GM) and the prevalence and prognosis of CKD. This cross-sectional study analyzed data from the U.S. National Health and Nutrition Examination Survey 2007-2020. DI-GM scores were calculated based on dietary intake of 14 food components, categorized as beneficial or unfavorable. Weighted linear regression model, logistic regression model, and restricted cubic spline analysis were used to assess the associations of DI-GM with CKD. The prevalence of CKD among 28,512 participants was 17.4 %. Higher DI-GM was negatively associated with CKD prevalence (OR = 0.967, 95 %CI: 0.939-0.995, = 0.026) and with very high-risk prognosis (OR = 0.877, 95 %CI: 0.821-0.937, < 0.001). Beneficial DI-GM components were significantly associated with lower CKD risk (OR = 0.928, 95 %CI: 0.892-0.966, < 0.001), while no significant association was observed for unfavorable components. Higher DI-GM and beneficial DI-GM levels were linearly associated with improved CKD prognosis ( for trend <0.001). Coffee and fiber were primary contributors to both the prevalence and prognosis of CKD, while whole grains primarily impacted its prognosis. Higher DI-GM, driven by beneficial dietary components, is associated with reduced CKD prevalence and improved prognosis. These findings suggest that promoting beneficial dietary patterns to enhance gut microbiota may play a pivotal role in CKD management.
新出现的证据表明,饮食可调节肠道微生物群,进而影响慢性肾脏病(CKD)的进展。本研究调查了新提出的肠道微生物群饮食指数(DI-GM)与CKD患病率及预后之间的关联。这项横断面研究分析了2007年至2020年美国国家健康与营养检查调查的数据。DI-GM得分是根据14种食物成分的饮食摄入量计算得出的,这些成分分为有益或不利两类。采用加权线性回归模型、逻辑回归模型和受限立方样条分析来评估DI-GM与CKD的关联。28512名参与者中CKD的患病率为17.4%。较高的DI-GM与CKD患病率呈负相关(OR = 0.967,95%CI:0.939 - 0.995,P = 0.026),与极高风险预后呈负相关(OR = 0.877,95%CI:0.821 - 0.937,P < 0.001)。有益的DI-GM成分与较低的CKD风险显著相关(OR = 0.928,95%CI:0.892 - 0.966,P < 0.001),而不利成分未观察到显著关联。较高的DI-GM和有益的DI-GM水平与改善的CKD预后呈线性相关(趋势P < 0.001)。咖啡和纤维是CKD患病率和预后的主要影响因素,而全谷物主要影响其预后。由有益饮食成分驱动的较高DI-GM与降低的CKD患病率和改善的预后相关。这些发现表明,促进有益的饮食模式以增强肠道微生物群可能在CKD管理中起关键作用。